Join an interactive live webinar examining real-world challenges and evidence-based strategies to optimize HER2 testing and treatment decision-making in advanced and metastatic non-small cell lung cancer (NSCLC).
Cutting-edge content, expert-led sessions, and interactive learning opportunities to equip attendees wit the latest insights and practical skills across key surgical disciplines
Expert faculty will discuss optimizing biomarker and genomic testing to personalize care, selecting effective first-line therapies, using sequential targeted options for disease progression, and more.
Learn how healthcare providers and wellness professionals can offer GLP-1 and peptide therapies through compliant, low-overhead models that expand services and improve patient outcomes.
✅ This 2 Day training + Extra day with Dr. Bing ✅ FREE Supplies ✅ Certification & 12 CME Credits ✅ Patient Consult, Mapping, Product Dosing + ✅ Extra-day on-site at Dr.’s location ✅ Offering Affirm as a payment method ✅ Lunch Both Days
The course integrates the science of precision Self-care, the wisdom of the 8 Principle Patterns of Traditional Chinese medicine philosophy, and the art of herbal medicine making. $349 - 14 hours
This TeleECHO series provides a comprehensive overview of current and emerging therapies for spondyloarthritis (SpA) conditions, translating the latest clinical data and guideline recommendations into practical, real-world applications for HCPs.
Join us for an engaging live symposium at the ATS 2026 International Conference where you will hear leading RCC experts provide valuable insights related to diagnosis, underlying pathophysiology, and the latest treatment advances on the horizon.
Endocrine resistance remains a key challenge in ER+/HER2- metastatic breast cancer, often driven by acquired ESR1 mutations. Early detection using ctDNA-based testing is essential for optimal integration of next-generation oral SERDs.